Analyzing OrthoPediatrics (NASDAQ:KIDS) & Nova Eye Medical (OTCMKTS:ELXMF)

OrthoPediatrics (NASDAQ:KIDSGet Free Report) and Nova Eye Medical (OTCMKTS:ELXMFGet Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and price targets for OrthoPediatrics and Nova Eye Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics 0 1 3 0 2.75
Nova Eye Medical 0 0 0 0 N/A

OrthoPediatrics currently has a consensus price target of $42.50, indicating a potential upside of 61.23%. Given OrthoPediatrics’ higher possible upside, equities analysts plainly believe OrthoPediatrics is more favorable than Nova Eye Medical.

Institutional & Insider Ownership

68.4% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 12.4% of Nova Eye Medical shares are owned by institutional investors. 32.6% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares OrthoPediatrics and Nova Eye Medical’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OrthoPediatrics $122.29 million 5.03 $1.26 million ($0.98) -26.90
Nova Eye Medical N/A N/A N/A $0.01 13.70

OrthoPediatrics has higher revenue and earnings than Nova Eye Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Nova Eye Medical, indicating that it is currently the more affordable of the two stocks.


This table compares OrthoPediatrics and Nova Eye Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OrthoPediatrics -15.57% -5.58% -4.88%
Nova Eye Medical N/A N/A N/A

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

About Nova Eye Medical

(Get Free Report)

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with's FREE daily email newsletter.